Literature DB >> 16188431

Spray freezing into liquid versus spray-freeze drying: influence of atomization on protein aggregation and biological activity.

Zhongshui Yu1, Keith P Johnston, Robert O Williams.   

Abstract

Protein aggregation and enzyme activity were compared for reconstituted lysozyme particles produced by two cryogenic technologies, spray freezing into liquid (SFL) and spray-freeze drying (SFD). The particles were characterized by enzyme activity measurements, scanning electron microscopy (SEM), light scattering, X-ray photoelectron spectroscopy (XPS) and BET specific surface area analysis. Highly porous microparticle aggregates of protein nanoparticles, observed by SEM, were produced by both processes. The smaller degree of protein aggregation and smaller losses in enzyme activity for the SFL process relative to the SFD process were due primarily to the spraying step. The higher stability of the SFL versus SFD powders was consistent with the smaller surface excess of lysozyme measured by XPS in SFL, resulting from the reduced time of exposure to the air-water interface during atomization. For pure lysozyme, the degree of aggregation and enzyme activity were comparable for lyophilization and SFL, despite the much larger particle surface area for SFL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188431     DOI: 10.1016/j.ejps.2005.08.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  16 in total

1.  Formation of stable submicron protein particles by thin film freezing.

Authors:  Joshua D Engstrom; Edwina S Lai; Baltej S Ludher; Bo Chen; Thomas E Milner; Robert O Williams; G Barrie Kitto; Keith P Johnston
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

Review 2.  Protein particulate detection issues in biotherapeutics development--current status.

Authors:  Tapan K Das
Journal:  AAPS PharmSciTech       Date:  2012-05-08       Impact factor: 3.246

3.  The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation.

Authors:  Sunday A Shoyele; Neeraj Sivadas; Sally-Ann Cryan
Journal:  AAPS PharmSciTech       Date:  2011-01-27       Impact factor: 3.246

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 5.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

6.  Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.

Authors:  Ashlee D Brunaugh; Tian Wu; Sekhar R Kanapuram; Hugh D C Smyth
Journal:  Mol Pharm       Date:  2019-08-26       Impact factor: 4.939

7.  Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.

Authors:  Udhumansha Ubaidulla; Molugu V S Reddy; Kumaresan Ruckmani; Farhan J Ahmad; Roop K Khar
Journal:  AAPS PharmSciTech       Date:  2007-01-19       Impact factor: 3.246

8.  A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.

Authors:  Xinran Li; Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2015-02-28       Impact factor: 9.776

9.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

10.  Low viscosity highly concentrated injectable nonaqueous suspensions of lysozyme microparticles.

Authors:  Maria A Miller; Joshua D Engstrom; Baltej S Ludher; Keith P Johnston
Journal:  Langmuir       Date:  2010-01-19       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.